Download
s10840-020-00898-5.pdf 659,35KB
WeightNameValue
1000 Titel
  • The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
1000 Autor/in
  1. Sinha, Anil-Martin |
  2. Bense, Jens |
  3. Hohenforst-Schmidt, Wolfgang |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-11-17
1000 Erschienen in
1000 Quellenangabe
  • 62(2):401-407
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s10840-020-00898-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536590/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!Large-scale multi-center studies have reported on efficacy of the wearable cardioverter-defibrillator (WCD). However, outcomes focused on WCD patients treated at community-based acute care centers are lacking.!##!Methods!#!Patients with cardiomyopathy were included when left ventricular ejection fraction (LVEF) at baseline was ≤ 35%. There were 120 patients meeting the criteria who also had LVEF measured at baseline and after 90 days of WCD use.!##!Results!#!After 90 days of WCD use, there were 44 (37%) patients in whom LVEF improved to > 35%. Comparison of patients, by whether LVEF improved or not, indicated that median days of WCD wear and hours of daily use were similar as well as characteristics, such as gender, age, and starting LVEF; and diagnoses leading to WCD prescription were similar between groups as were symptom-based prescription of medications. At the end of WCD use, improved LVEF > 35% correlated with fewer implantable cardioverter-defibrillator (ICD) implants. There were 4 (3%) episodes of new atrial fibrillation detected during WCD use. The WCD appropriately delivered a shock to 3 (2.5%) patients with VT/VF being terminated by the first shock. All shocked patients survived for at least 24 h post-shock.!##!Conclusions!#!During WCD use, ischemic and non-ischemic cardiomyopathy patients manifest improved LVEF by 90 days. Long-term care decisions, such as implantation of an ICD, were influenced by LVEF improvement and occurrence of spontaneous VT/VF. The WCD protected patients from sudden cardiac death (SCD) until patient response to guideline-directed medical therapy could be determined.
1000 Sacherschließung
lokal Defibrillators, Implantable [MeSH]
lokal Ventricular Function, Left [MeSH]
lokal Arrhythmia
lokal Death, Sudden, Cardiac/epidemiology [MeSH]
lokal Humans [MeSH]
lokal Electric Countershock [MeSH]
lokal Wearable Electronic Devices [MeSH]
lokal Hospitals [MeSH]
lokal Sudden cardiac death
lokal Article
lokal Death, Sudden, Cardiac/prevention
lokal Cardiomyopathy
lokal Stroke Volume [MeSH]
lokal Wearable cardioverter-defibrillator
lokal Defibrillators [MeSH]
lokal Implantable cardioverter-defibrillator
lokal Sudden cardiac arrest
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2luaGEsIEFuaWwtTWFydGlu|https://frl.publisso.de/adhoc/uri/QmVuc2UsIEplbnM=|https://frl.publisso.de/adhoc/uri/SG9oZW5mb3JzdC1TY2htaWR0LCBXb2xmZ2FuZw==
1000 Hinweis
  • DeepGreen-ID: 22d2bf5a0fb646f281e7f2e4d6dada0f ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466512.rdf
1000 Erstellt am 2023-11-16T23:55:53.103+0100
1000 Erstellt von 322
1000 beschreibt frl:6466512
1000 Zuletzt bearbeitet Fri Dec 01 04:24:17 CET 2023
1000 Objekt bearb. Fri Dec 01 04:24:17 CET 2023
1000 Vgl. frl:6466512
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466512 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source